Table 3.
Long-term outcomes
| Secondary cancers (n = 26) | 23% (6) |
| Adjuvant therapy (n = 26) | |
| Chemo XRT | 12% (3) |
| Chemo | 15% (4) |
| XRT | 4% (1) |
| Adjuvant therapy offered and refused | 19% (5) |
| None | 50% (13) |
| Survival (4 y after) | |
| Deaths | 15% (4) |
| Metastatic recurrent cancer | 15% (4) |
Percentages are based on an “n” of 26 noncarcinoid lung cancers. XRT, Radiotherapy.